Laboratory pipette with drop of liquid over glass test tubes in a science research lab

19 May 2021 - AGM statement

An encouraging statement on trading will be made at today's AGM confirming that the group continues to see some strong performances from its key brands.  The integration of the Biogix business and the Amberen brand into the group's US operations is progressing well, and the company is on track to deliver full year results in line with expectations.  Although the shares are already up by almost 10% since our tip in March, they remain a BUY

This content is restricted to members only. We offer three packages from 1 month to a whole year of daily tips, market news and commentary, plus our monthly newsletters.
Registration is quick and simple HERE.

Already a member, log in HERE.